Director Robert Demichiei buys 11,260 shares of ARDT at $8.73, raising holdings to 35,564 shares; stock down -44.2% from 52-week high.
Director Robert Demichiei purchased 11,260 shares at $8.73 on 2026-06-05, increasing his shareholding by 46.3% from 24,304 to 35,564 shares for a total investment of $98,299.80. The purchase occurs with the stock trading at $8.64, down -44.2% from its 52-week high of $15.48 and down -14.5% over the past 30 days. Ardent Health trades at a P/E of 9.19 with positive fundamentals including $1.6B in quarterly revenue, $39.8M in net income, and 6.0% annual revenue growth, suggesting the depressed price may reflect market sentiment rather than deteriorating business performance. The substantial increase in Demichiei's ownership stake warrants tracking to establish whether this represents a broader pattern of insider accumulation at current valuations.